Information
-
Trademark
-
88880733
-
Serial Number
88880733
-
Registration Number
6741952
-
International Classifications
-
Filing Date
April 21, 2020
4 years ago
-
Registration Date
May 31, 2022
2 years ago
-
Transaction Date
May 31, 2022
2 years ago
-
Status Date
May 31, 2022
2 years ago
-
Published for Opposition Date
November 02, 2021
3 years ago
-
Location Date
May 31, 2022
2 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
RIOS, SASHA BOSHART
-
Attorney Docket Number
594.807US01
Attorney Name
Danielle I. Mattessich
Law Office Assigned Location Code
N70
-
Owners
Case File Statements
- DM0000: The mark consists of a hollow sphere design outlined by brush-strokes resembling blue, red, and white ribbons. The upper left part of the sphere has a blue stripe going to the bottom left, having a gleam and showing color gradation. The bottom part to the right side of sphere is outlined by a navy blue stripe. There is also a thin red stripe across the center of the sphere from the top to the bottom, and a white streak from the top right to the bottom left of the sphere. The light blue ribbon does not touch the dark blue ribbon. The background on which the design is placed and the center of the sphere represents transparent area.
- GS0051: Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical preparations containing stem cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical composition containing cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical composition containing stem cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction,spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD)
- CC0000: The colors white, blue, and red are claimed as a feature of the mark.
Case File Event Statements
-
5/31/2022 - 2 years ago
40 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
5/31/2022 - 2 years ago
39 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
4/26/2022 - 2 years ago
38 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION
Type: DP1B
-
3/15/2022 - 2 years ago
37 - NOTICE OF ALLOWANCE CANCELLED
Type: IUCN
-
4/26/2022 - 2 years ago
36 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
3/15/2022 - 2 years ago
35 - TEAS DELETE 1(B) BASIS RECEIVED
Type: D1BR
-
12/28/2021 - 3 years ago
34 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
11/2/2021 - 3 years ago
33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
11/2/2021 - 3 years ago
32 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
10/13/2021 - 3 years ago
31 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
9/28/2021 - 3 years ago
30 - ELECTRONIC RECORD REVIEW COMPLETE
Type: FIXD
-
9/24/2021 - 3 years ago
29 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Type: ERRR
-
9/20/2021 - 3 years ago
28 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
9/20/2021 - 3 years ago
27 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
9/20/2021 - 3 years ago
26 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
9/20/2021 - 3 years ago
25 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
9/20/2021 - 3 years ago
24 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
8/31/2021 - 3 years ago
23 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/31/2021 - 3 years ago
22 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/31/2021 - 3 years ago
21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
8/23/2021 - 3 years ago
20 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
8/23/2021 - 3 years ago
19 - FINAL REFUSAL E-MAILED
Type: GNFR
-
8/23/2021 - 3 years ago
18 - FINAL REFUSAL WRITTEN
Type: CNFR
-
7/19/2021 - 3 years ago
17 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
7/19/2021 - 3 years ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
7/15/2021 - 3 years ago
15 - ASSIGNED TO LIE
Type: ALIE
-
6/15/2021 - 3 years ago
14 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Type: ERSI
-
1/28/2021 - 3 years ago
13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
1/28/2021 - 3 years ago
12 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
1/28/2021 - 3 years ago
11 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
1/15/2021 - 4 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
1/15/2021 - 4 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
1/15/2021 - 4 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
7/15/2020 - 4 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
7/15/2020 - 4 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
7/15/2020 - 4 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
7/14/2020 - 4 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/1/2020 - 4 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
4/30/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
4/24/2020 - 4 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP